FDA Inspection
Aurolife Pharma, LLCAurolife Pharma, LLC – FDA Inspection, Jun 14, 2018
Record Details
This FDA Inspection record concerns Aurolife Pharma, LLC, with an inspection on June 14, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · af02282b-baad-459c-ab27-5f81e3b9e7be
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1055912
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Aurolife Pharma, LLC
9| Date | Classification | Office | Project area |
|---|---|---|---|
| December 7, 2021 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 28, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 12, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 9, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Aurolife Pharma, LLC
- FDA Inspection 1158258 - 2021-12-07
- FDA Inspection 1109452 - 2019-10-22
- FDA Inspection 980107 - 2016-07-28
- FDA Inspection 952634 - 2016-01-12
- FDA Inspection 933659 - 2015-07-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.